Competitive, Meaningful Work
Update: 2025-02-05
Description
Jonathan Violin, CEO of Crescent Biopharma and Venture Partner at Fairmount, speaks with Venrock partner Nimish Shah about how the company is keeping a frenetic and exciting pace to generate a new class of drugs while preparing to launch on the public markets later this year.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
